Enliven Therapeutics Inc.

NASDAQ: ELVN
Share price (3/25/25): $21.32
Market cap (3/25/25): $1.045 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Exempt offering of securities

Ownership Filter

Lyssikatos Joseph P

Lyssikatos Joseph P

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Reports Third Quarter Financial Results and Provides a Business Update

Reports Second Quarter Financial Results and Provides a Business Update

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC